Please assess the completion status of the following clinical trial:

Trial Title: Modified-FLAI Induction and Consolidation Chemotherapy in Elderly Patient With Acute Myeloid Leukemia (AML)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* previously untreated AML (excluding acute promyelocytic leukemia)~* age greater than 60 years old~* ECOG PS (Eastern Cooperative Oncology Group Performance scale) less than 2~* adequate hepatic/ renal/ cardiac function~Exclusion Criteria:~* acute promyelocytic leukemia~* significant cardiac disease~* combined non-hematologic malignancy~* aleukemic leukemia (only granulocytic sarcoma)~* CNS (Central Nervous system) involvement~* significant comorbidity/ uncontrollable bleeding tendency

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).